Kitov pharma ltd. (KTOV)
Income statement / Yearly
Dec'17Dec'16Dec'15
Research and development expenses

4,640

4,180

2,560

General and administrative expenses

6,392

3,003

1,509

Other expenses (income), net

1,029

0

0

Operating loss

-12,061

-7,183

-4,069

Net change in fair value of derivatives

-1,049

-5,019

94

Finance expense

26

61

227

Finance income

128

138

0

Finance expenses, net

947

4,942

133

Loss for the year

-13,008

-12,125

-4,202

Re-measurement of defined benefit liability

95

21

0

Total comprehensive loss for the year

-13,103

-12,146

-4,202

Loss attributable to:
Owners of the Company

12,272

12,125

4,202

Non-controlling interests

736

0

0

Total Loss attributable

13,008

12,125

4,202

Owners of the Company

12,367

12,146

4,202

Non-controlling interests

736

0

0

Total comprehensive loss for the year

-13,103

-12,146

-4,202

Loss per share
Basic and diluted loss per share - USD

0.07

0.11

0.22

Number of shares used in calculation

189,139

115,114

19,250